Average Insider

Where insiders trade, we follow

$CGEM
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Healthcare
Sector
Medical - Pharmaceuticals
Industry
Nadim Ahmed
CEO
111
Employees
$20.34
Current Price
$819.98M
Market Cap
52W Low$5.68
Current$20.3495.7% above low, 4.3% below high
52W High$21.00

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00--All Sells
Sells11$607,800.0030,000
2 weeksBuys00--All Sells
Sells11$607,800.0030,000
1 monthBuys00--All Sells
Sells11$607,800.0030,000
2 monthsBuys00--All Sells
Sells12$750,360.0038,000
3 monthsBuys00--All Sells
Sells12$750,360.0038,000
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Aug 13, 2026
Michaelson Jennifer
Chief Scientific Officer
Sale30,000$20.26$607,800.00View Details
Jul 6, 2026
Michaelson Jennifer
Chief Scientific Officer
Sale8,000$17.82$142,560.00View Details
32 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.7.3